Menu
Washingtoner
  • Home
  • Artificial Intelligence
  • Health
  • Technology
  • Entertainment
  • Software
  • Real Estate
  • Business
  • Education
Washingtoner

Patent-Pending Athletic Mouthguard with Integrated Inhaler Respirator Offers On-Demand Medication Access During Sports Play
Washingtoner/10317474

Trending...
  • Global Leaders Convene in Seattle to Advance Responsible AI and Cross-Border Ecosystems
  • AI Needs Guardrails Now: A New Movement Asks People Everywhere to Take the Pledge
  • RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
Patent Cover 1
Revolutionary Athletic Mouthguard with Integrated Inhaler Respirator Now Available for Licensing

CHICAGO - Washingtoner -- A groundbreaking innovation in sports health and performance has been introduced with the publication of US 2025/0367391 A1, titled Athletic Mouthguard Having an Integrated Inhaler Respirator

US20250367391A1

.

This patent-pending technology integrates an inhaler respirator directly into a protective athletic mouthguard, allowing athletes to access medication instantly—without leaving the game.

Solving a Critical Problem in Sports

Traditional inhalers must be retrieved from the sidelines or athletic bags. This delay can impact performance and safety—especially for athletes managing asthma or respiratory conditions.

This innovative design:
  • Integrates a medication delivery system directly into a mouthguard
  • Allows on-demand expulsion of medication via a press-button mechanism
  • Stores medication within an internal chamber
  • Uses a propellant system for effective delivery
  • Provides immediate access during play

As illustrated in the patent figures, the inhaler respirator is removably coupled to the mouthguard and includes a medication cartridge with controlled expulsion openings

More on Washingtoner
  • Spokane: Drugs and Guns Seized in a Counter Narcotics Investigation
  • Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
  • The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
  • Spokane: City and County Issue Joint Housing and Homelessness Funding RFP
  • Spokane: Council Approves Additional Funding to Prepare for Inclement Weather

US20250367391A1

.

Key Advantages
  • Immediate respiratory access during athletic activity
  • Eliminates need to leave the field
  • Combines protection + medication delivery
  • Potential asthma relief and performance enhancement applications
  • Rechargeable or replaceable medication embodiments

Market Opportunity

The global sports mouthguard market combined with asthma inhaler demand represents a significant cross-category opportunity in:
  • Youth sports
  • High school athletics
  • Collegiate programs
  • Professional sports
  • Combat sports
  • Training facilities

Available for Licensing

This patent-pending technology is currently available for licensing partnerships with:
  • Sporting goods manufacturers
  • Athletic equipment brands
  • Medical device companies
  • Respiratory therapy companies

For licensing inquiries or product development discussions, please contact:
Axis International Marketing Ltd.
WWW.123axis.com
847-297-0744
customercare@123axis.com

Contact
ANDY BERGER
***@aol.com


Source: Axis International Marketing

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
  • Spokane: City And County Seek Federal Grant to Plan for Road Network Wildfire Resilience
  • The Great Junk Hunt Returns to Monroe: Kick Off Your Holiday Shopping at the Ultimate Vintage Treas
  • AI Trading Agents Track Aerospace and Defense US Stocks Amid Rising Technology Investment (SATS, GILT, TSAT, IREN, JOBY, LUNR)
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Evluma's RoadMax Edge Roadway Luminaires Earn DarkSky Approved Status
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Tacoma: Public Hearing for Off-Street Parking Code Update Set for December 1
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • Spokane: SPD Makes an Arrest in Yesterday's Early Morning Shooting
  • Spokane: Mayor Brown Introduces 2027-2028 Budget Proposal
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
  • IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
  • Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
  • P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane: City and Permittable Partner to Support Rebuilding After Wildfires - 307
  • Spokane: City to provide asbestos testing, host community resource meetings - 255
  • Tacoma: In-Person Workshop on October 22 for Local Businesses on the City’s Revolving Loan Fund Process - 212
  • Pre-Seed VC Martin Tobias Makes Fundraising Tool Available to Every Startup CEO as Investor Match - 182
  • Final Week to Register for Free Spokane Community Conference - 151
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX) - 148
  • Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1 - 147
  • Geospatial Innovation Comes to Sacramento: FOSS4G NA 2026 - 115
  • Holiday Gambling Spending Expected to Rise 12% in December - 111
  • Author Robert A. Robinson Introduces Anarchy at the AYP: - 111

Similar on Washingtoner

  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
  • Tampa Holiday Sessions: Captured by Mallary Opens 2026 Christmas Minis With Two New Sets
  • RPP to host first Professional Padel Week in Miami and announce the 2026 USA Awards winners
  • AthleteMerch.com Surpasses 100,000 Custom Items Delivered to Fans Nationwide
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute